{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2020-12-18", "title": "SDTM Controlled Terminology Package 44 Effective 2020-12-18", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2020-11-06/codelists/C96785", "title": "CDISC SDTM Tumor Response Result Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C96785", "title": "Version-agnostic anchor resource for codelist C96785", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2020-12-18/codelists/C96785", "title": "CDISC SDTM Tumor Response Result Terminology", "type": "Code List"}}, "conceptId": "C96785", "definition": "Terminology for oncology studies relevant to the result of response to treatment or therapy assessment within the disease response and clinical classification domain.", "extensible": "true", "name": "Oncology Response Assessment Result", "preferredTerm": "CDISC SDTM Tumor Response Result Terminology", "submissionValue": "ONCRSR", "synonyms": ["Oncology Response Assessment Result"], "terms": [{"conceptId": "C123571", "definition": "The absence of change in the overall attenuation of the metastasis and in the peripheral rim, suggesting a lack of response to treatment.", "preferredTerm": "Absent Morphologic Response", "submissionValue": "ABSENT MORPHOLOGIC RESPONSE"}, {"conceptId": "C123572", "definition": "The amount of cancer antigen 125 is reduced by 50% from protocol-defined baseline value(s).", "preferredTerm": "CA125 50% Response", "submissionValue": "CA125 50% RESPONSE", "synonyms": ["Cancer Antigen 125 50% Response"]}, {"conceptId": "C123573", "definition": "The amount of cancer antigen 125 is reduced by 75% from protocol-defined baseline value(s).", "preferredTerm": "CA125 75% Response", "submissionValue": "CA125 75% RESPONSE", "synonyms": ["Cancer Antigen 125 75% Response"]}, {"conceptId": "C123574", "definition": "The disappearance of all signs of cancer based on physical exam, such as palpation.", "preferredTerm": "Clinical Complete Response", "submissionValue": "cCR", "synonyms": ["Clinical Complete Remission", "Clinical Complete Response"]}, {"conceptId": "C123575", "definition": "The disappearance of cancer in response to treatment, including platelet and white blood cell counts returning to normal levels, a non-palpable spleen, and no immature white blood cells present in the blood unless it is a regenerating marrow following treatment.", "preferredTerm": "Complete Hematologic Response", "submissionValue": "CHR", "synonyms": ["Complete Hematologic Response"]}, {"conceptId": "C123407", "definition": "The disappearance of metabolic tumor activity in all relevant lesions.", "preferredTerm": "Tumor Complete Metabolic Response", "submissionValue": "CMR", "synonyms": ["Complete Metabolic Response"]}, {"conceptId": "C124427", "definition": "Absence of residual disease based on pre-defined thresholds and minimal residual disease negativity by laboratory techniques.", "preferredTerm": "Complete Minimal Residual Disease Response", "submissionValue": "COMPLETE MRD RESPONSE", "synonyms": ["Complete Minimal Residual Disease Response"]}, {"conceptId": "C123576", "definition": "A decrease in the size and the extent of tissue involvement by cancer, based on physical exam, such as palpation.", "preferredTerm": "Clinical Partial Response", "submissionValue": "cPR", "synonyms": ["Clinical Partial Remission", "Clinical Partial Response"]}, {"conceptId": "C4870", "definition": "The disappearance of all signs of cancer in response to treatment. (NCI)", "preferredTerm": "Complete Remission", "submissionValue": "CR", "synonyms": ["Complete Remission", "Complete Response"]}, {"conceptId": "C123577", "definition": "The disappearance of all signs of cancer, based on CT scan and criteria-defined assessments.", "preferredTerm": "Complete Response by Computed Tomography", "submissionValue": "CR-CT", "synonyms": ["Complete Remission, CT-Based", "Complete Response, CT-Based"]}, {"conceptId": "C103385", "definition": "The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.", "preferredTerm": "Complete Response with Incomplete Bone Marrow Recovery", "submissionValue": "CRi", "synonyms": ["Complete Remission with Incomplete Blood Count Recovery", "Complete Response with Incomplete Bone Marrow Recovery"]}, {"conceptId": "C123578", "definition": "The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.", "preferredTerm": "Cytogenetic Complete Response", "submissionValue": "CYTOGENETIC CR", "synonyms": ["CCgR", "CCyR", "CRc", "Complete Cytogenetic Response", "Cytogenetic Complete Remission", "Cytogenetic Complete Response"]}, {"conceptId": "C123579", "definition": "A minimal decrease in abnormal karyotype, based on pre-defined thresholds.", "preferredTerm": "Cytogenetic Minimal Response", "submissionValue": "CYTOGENETIC MINIMAL RESPONSE", "synonyms": ["Minimal CgR"]}, {"conceptId": "C123580", "definition": "A minor decrease in abnormal karyotype, based on pre-defined thresholds.", "preferredTerm": "Cytogenetic Minor Response", "submissionValue": "CYTOGENETIC MINOR RESPONSE", "synonyms": ["Minor CgR"]}, {"conceptId": "C123581", "definition": "No change in abnormal karyotype, based on pre-defined thresholds.", "preferredTerm": "Cytogenetic No Response", "submissionValue": "CYTOGENETIC NO RESPONSE", "synonyms": ["No CgR", "No Cytogenetic Response"]}, {"conceptId": "C123582", "definition": "A partial decrease in abnormal karyotype, based on pre-defined thresholds.", "preferredTerm": "Cytogenetic Partial Response", "submissionValue": "CYTOGENETIC PR", "synonyms": ["Cytogenetic Partial Response", "Partial CgR"]}, {"conceptId": "C25640", "definition": "Made less in size, amount, degree, or extent.", "preferredTerm": "Reduced", "submissionValue": "DECREASED", "synonyms": ["Reduced"]}, {"conceptId": "C123583", "definition": "A conversion from one disease diagnosis to another, which may be considered a progression to a worsening state.", "preferredTerm": "Disease Transformation", "submissionValue": "DISEASE TRANSFORMATION"}, {"conceptId": "C86071", "definition": "Open to question.", "preferredTerm": "Equivocal", "submissionValue": "EQUIVOCAL"}, {"conceptId": "C123584", "definition": "No new lesions(s) and a decrease in lesion size, or a reduction in central necrosis or attenuation in one or more enhancing lesions, based on pre-defined thresholds.", "preferredTerm": "Favorable Response", "submissionValue": "FAVORABLE RESPONSE"}, {"conceptId": "C123585", "definition": "An improvement in erythrocyte count as a response to treatment.", "preferredTerm": "Hematologic Improvement-Erythroid Response", "submissionValue": "HI-E", "synonyms": ["Hematologic Improvement-Erythroid Response"]}, {"conceptId": "C123586", "definition": "An improvement of neutrophil count as a response to treatment.", "preferredTerm": "Hematologic Improvement-Neutrophil Response", "submissionValue": "HI-N", "synonyms": ["Hematologic Improvement-Neutrophil Response"]}, {"conceptId": "C123587", "definition": "An improvement of platelet count as a response to treatment.", "preferredTerm": "Hematologic Improvement-Platelet Response", "submissionValue": "HI-P", "synonyms": ["Hematologic Improvement-Platelet Response"]}, {"conceptId": "C142356", "definition": "Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.", "preferredTerm": "iRECIST Confirmed Progressive Disease", "submissionValue": "iCPD"}, {"conceptId": "C142357", "definition": "The disappearance of all signs of cancer following an initial apparent radiographic progression.", "preferredTerm": "iRECIST Complete Response", "submissionValue": "iCR"}, {"conceptId": "C123588", "definition": "The disappearance of all signs of cancer, supported by the absence of phenotypically aberrant plasma cells (clonal) in bone marrow. (Rajkumar SV, Harousseau J, Durie B et al, Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011; 117(18):4691-4695)", "preferredTerm": "Immunophenotypic Complete Response", "submissionValue": "IMMUNOPHENOTYPIC CR", "synonyms": ["Immunophenotypic Complete Response"]}, {"conceptId": "C125459", "definition": "A subjective response indicating that something has improved or gotten better.", "preferredTerm": "Improved", "submissionValue": "IMPROVED", "synonyms": ["Better"]}, {"conceptId": "C25533", "definition": "A process of becoming larger, more intense, more extensive, more numerous, more important, or more likely.", "preferredTerm": "Increase", "submissionValue": "INCREASED"}, {"conceptId": "C123589", "definition": "A response that is neither favorable nor unfavorable.", "preferredTerm": "Indeterminate Response", "submissionValue": "INDETERMINATE RESPONSE"}, {"conceptId": "C142358", "definition": "A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression.", "preferredTerm": "iRECIST Partial Response", "submissionValue": "iPR"}, {"conceptId": "C142359", "definition": "Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression.", "preferredTerm": "iRECIST Stable Disease", "submissionValue": "iSD"}, {"conceptId": "C142360", "definition": "Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.", "preferredTerm": "iRECIST Unconfirmed Progressive Disease", "submissionValue": "iUPD"}, {"conceptId": "C123590", "definition": "A major decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds.", "preferredTerm": "Major Pathologic Response", "submissionValue": "MAJOR PATHOLOGIC RESPONSE"}, {"conceptId": "C123591", "definition": "A decrease in the number of bone marrow plasma cells to protocol-defined level(s).", "preferredTerm": "Marrow Complete Response", "submissionValue": "mCR", "synonyms": ["Marrow Complete Remission", "Marrow Complete Response"]}, {"conceptId": "C123592", "definition": "A minor decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds.", "preferredTerm": "Minor Pathologic Response", "submissionValue": "MINOR PATHOLOGIC RESPONSE"}, {"conceptId": "C123593", "definition": "The disappearance of all signs of cancer, supported by molecular analysis.", "preferredTerm": "Molecular Complete Response", "submissionValue": "MOLECULAR CR", "synonyms": ["CMR", "Complete Molecular Response", "Molecular Complete Remission", "Molecular Complete Response"]}, {"conceptId": "C123594", "definition": "A decrease in signs of cancer, supported by molecular analysis.", "preferredTerm": "Molecular Major Response", "submissionValue": "MOLECULAR MAJOR RESPONSE", "synonyms": ["MMR", "MMolR", "Major Molecular Response"]}, {"conceptId": "C123595", "definition": "The disappearance of all signs of cancer, supported by morphological analysis.", "preferredTerm": "Morphologic Complete Response", "submissionValue": "MORPHOLOGIC CR", "synonyms": ["Morphologic Complete Remission", "Morphologic Complete Response"]}, {"conceptId": "C123596", "definition": "The disappearance of all cells with morphologic characteristics of cancer, accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.", "preferredTerm": "Morphologic Complete Remission with Incomplete Blood Count Recovery", "submissionValue": "MORPHOLOGIC CRi", "synonyms": ["Morphologic Complete Remission with Incomplete Blood Count Recovery", "Morphologic Complete Remission with Incomplete Bone Marrow Recovery"]}, {"conceptId": "C123597", "definition": "The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow.", "preferredTerm": "Morphologic Leukemia-Free State", "submissionValue": "MORPHOLOGIC LEUKEMIA-FREE STATE", "synonyms": ["NEL", "No Evidence of Leukemia"]}, {"conceptId": "C123598", "definition": "A finding that refers to hematologic and solid malignancies and indicates that there is a minor improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.", "preferredTerm": "Minimal Response", "submissionValue": "MR", "synonyms": ["Minimal Response", "Minor Response"]}, {"conceptId": "C124428", "definition": "Absence of minimal residual disease based on laboratory techniques.", "preferredTerm": "Minimal Residual Disease Negativity", "submissionValue": "MRD NEGATIVITY", "synonyms": ["Minimal Residual Disease Negativity"]}, {"conceptId": "C124429", "definition": "Presence of residual disease based on pre-defined thresholds and quantifiable minimal residual disease positivity by laboratory techniques.", "preferredTerm": "Minimal Residual Disease Persistence", "submissionValue": "MRD PERSISTENCE", "synonyms": ["Minimal Residual Disease Persistence"]}, {"conceptId": "C124430", "definition": "Presence of residual disease based on pre-defined thresholds and return of quantifiable minimal residual disease positivity after a period of minimal residual disease negativity.", "preferredTerm": "Minimal Residual Disease Relapse", "submissionValue": "MRD RELAPSE", "synonyms": ["MRD Reappearance", "Minimal Residual Disease Relapse"]}, {"conceptId": "C62222", "definition": "Unable to be evaluated. (NCI)", "preferredTerm": "Unevaluable", "submissionValue": "NE", "synonyms": ["Not Assessable", "Not Evaluable"]}, {"conceptId": "C40413", "definition": "An absence of detectable disease.", "preferredTerm": "No Evidence of Disease", "submissionValue": "NED", "synonyms": ["No Evidence of Disease"]}, {"conceptId": "C96700", "definition": "Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)", "preferredTerm": "Non Complete Response/Non Progressive Disease", "submissionValue": "NON-CR/NON-PD", "synonyms": ["Non Complete Response/Non Progressive Disease"]}, {"conceptId": "C142361", "definition": "Persistence of one or more non-target lesion(s) without unequivocal progression following an initial apparent radiographic progression.", "preferredTerm": "Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease", "submissionValue": "NON-iCR/NON-iUPD"}, {"conceptId": "C123599", "definition": "Following a previous assessment of progressive disease unconfirmed (PDu) of non-target lesion(s), the subsequent required assessment does not confirm progressive disease.", "preferredTerm": "Non Progressive Disease", "submissionValue": "NON-PD", "synonyms": ["Non Progressive Disease"]}, {"conceptId": "C124431", "definition": "Presence of non-quantifiable minimal residual disease based on laboratory techniques.", "preferredTerm": "Non-Quantifiable Minimal Residual Disease Positivity", "submissionValue": "NON-QUANTIFIABLE MRD POSITIVITY", "synonyms": ["Non-Quantifiable Minimal Residual Disease Positivity"]}, {"conceptId": "C161412", "definition": "An indication that the subject's steroid dose is the same as their physiologic replacement dose.", "preferredTerm": "No Steroid Use Beyond Physiologic Replacement Dose", "submissionValue": "NONE BEYOND PHYSIOLOGIC REPLACEMENT DOSE"}, {"conceptId": "C103424", "definition": "Not all target lesions were assessed. Or not all non-target lesions were assessed.", "preferredTerm": "Not All Lesions Evaluated", "submissionValue": "NOT ALL EVALUATED", "synonyms": ["Not All Evaluated"]}, {"conceptId": "C70633", "definition": "Remission with remaining lymphoid nodules reflecting residual disease.", "preferredTerm": "Nodular Partial Remission", "submissionValue": "nPR", "synonyms": ["Nodular Partial Response"]}, {"conceptId": "C123600", "definition": "No apparent change or worsening in lesion staging classification.", "preferredTerm": "No Response", "submissionValue": "NR", "synonyms": ["No Response"]}, {"conceptId": "C123601", "definition": "Hypo-attenuation of the metastases which may appear pseudocystic, perfectly homogeneous, and devoid of a recognizable peripheral rim.", "preferredTerm": "Optimal Morphologic Response", "submissionValue": "OPTIMAL MORPHOLOGIC RESPONSE"}, {"conceptId": "C123602", "definition": "Mixed attenuation and some homogeneity of the metastases with a partially resolved peripheral rim.", "preferredTerm": "Partial Morphologic Response", "submissionValue": "PARTIAL MORPHOLOGIC RESPONSE"}, {"conceptId": "C123603", "definition": "The disappearance of all signs of cancer, supported by pathological examination.", "preferredTerm": "Pathologic Complete Response", "submissionValue": "pCR", "synonyms": ["Complete Pathological Response", "Pathologic Complete Remission", "Pathologic Complete Response"]}, {"conceptId": "C35571", "definition": "A disease process that is increasing in extent or severity. (NCI)", "preferredTerm": "Progressive Disease", "submissionValue": "PD", "synonyms": ["Disease Progression", "Progressive Disease"]}, {"conceptId": "C123604", "definition": "Disease progression occurring after a partial response.", "preferredTerm": "Progression from Partial Response", "submissionValue": "PD FROM PR", "synonyms": ["Progression from PR", "Progressive Disease from Partial Response"]}, {"conceptId": "C123606", "definition": "There is an increase in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments.", "preferredTerm": "Progressive Disease by Computed Tomography", "submissionValue": "PD-CT", "synonyms": ["Progressive Disease, CT-Based"]}, {"conceptId": "C123605", "definition": "Disease progression or the return of a disease after a period of remission, occurring after a hematologic improvement.", "preferredTerm": "Progression or Relapse After Hematologic Improvement", "submissionValue": "PD/RELAPSE AFTER HI", "synonyms": ["Progression or Relapse After Hematologic Improvement"]}, {"conceptId": "C123607", "definition": "A disease process that is increasing in scope or severity but the criteria for progressive disease is not met.", "preferredTerm": "Unconfirmed Progressive Disease", "submissionValue": "PDu", "synonyms": ["PD Unconfirmed", "Unconfirmed Progressive Disease"]}, {"conceptId": "C123608", "definition": "An increase of metabolic tumor activity in all relevant lesions, based on pre-defined thresholds, or the development of new lesions.", "preferredTerm": "Progressive Metabolic Disease", "submissionValue": "PMD", "synonyms": ["Progressive Metabolic Disease"]}, {"conceptId": "C123609", "definition": "A decrease of metabolic tumor activity in all relevant lesions, based on a pre-defined threshold.", "preferredTerm": "Partial Metabolic Response", "submissionValue": "PMR", "synonyms": ["Partial Metabolic Response"]}, {"conceptId": "C18058", "definition": "A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer.", "preferredTerm": "Partial Remission", "submissionValue": "PR", "synonyms": ["Partial Remission", "Partial Response"]}, {"conceptId": "C128998", "definition": "A decrease in the size and the extent of tissue involvement by cancer, accompanied by an increase in blood lymphocyte count above a predetermined threshold.", "preferredTerm": "Partial Response with Lymphocytosis", "submissionValue": "PR WITH LYMPHOCYTOSIS", "synonyms": ["PR-L", "PRL", "Partial Response with Lymphocytosis"]}, {"conceptId": "C123610", "definition": "A decrease in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments.", "preferredTerm": "Partial Response by Computed Tomography", "submissionValue": "PR-CT", "synonyms": ["Partial Remission, CT-Based", "Partial Response, CT-Based"]}, {"conceptId": "C123611", "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.", "preferredTerm": "PSA Progression", "submissionValue": "PSA PROGRESSION", "synonyms": ["Prostate Specific Antigen Progression"]}, {"conceptId": "C98298", "definition": "Apparent increase in lesion burden, not proven to be disease progression.", "preferredTerm": "Pseudoprogression", "submissionValue": "PSEUDOPROGRESSION"}, {"conceptId": "C131142", "definition": "Apparent decrease in lesion burden, not proven to be favorable treatment response.", "preferredTerm": "Pseudoresponse", "submissionValue": "PSEUDORESPONSE"}, {"conceptId": "C124432", "definition": "Presence of quantifiable minimal residual disease based on laboratory techniques.", "preferredTerm": "Quantifiable Minimal Residual Disease Positivity", "submissionValue": "QUANTIFIABLE MRD POSITIVITY", "synonyms": ["Quantifiable Minimal Residual Disease Positivity"]}, {"conceptId": "C38155", "definition": "The return of a disease after a period of remission.", "preferredTerm": "Recurrent Disease", "submissionValue": "RELAPSED DISEASE", "synonyms": ["Recurrent Disease"]}, {"conceptId": "C123612", "definition": "The return of a disease after a period of complete remission.", "preferredTerm": "Relapsed Disease From Complete Response", "submissionValue": "RELAPSED DISEASE FROM CR", "synonyms": ["Relapse from CR", "Relapsed Disease From Complete Response"]}, {"conceptId": "C123613", "definition": "The return of a disease after a period of complete remission or partial remission.", "preferredTerm": "Relapsed Disease From Complete or Partial Response", "submissionValue": "RELAPSED DISEASE FROM CR OR PR", "synonyms": ["Relapsed Disease From Complete Response or Partial Response"]}, {"conceptId": "C123614", "definition": "The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.", "preferredTerm": "Stringent Complete Response", "submissionValue": "sCR", "synonyms": ["Stringent Complete Remission", "Stringent Complete Response"]}, {"conceptId": "C18213", "definition": "Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries. (NCI)", "preferredTerm": "Stable Disease", "submissionValue": "SD", "synonyms": ["Stable Disease"]}, {"conceptId": "C123615", "definition": "The size and extent of tissue involvement by cancer is neither decreasing nor increasing, based on CT scan and criteria-defined assessments.", "preferredTerm": "Stable Disease by Computed Tomography", "submissionValue": "SD-CT", "synonyms": ["Stable Disease, CT-Based"]}, {"conceptId": "C123616", "definition": "The absence of change or mild changes of metabolic tumor activity in all relevant lesions based on a pre-defined threshold.", "preferredTerm": "Stable Metabolic Disease", "submissionValue": "SMD", "synonyms": ["NMR", "No Metabolic Response", "Stable Metabolic Disease"]}, {"conceptId": "C30103", "definition": "Subject to little fluctuation; showing little if any change. (NCI)", "preferredTerm": "Stable", "submissionValue": "STABLE"}, {"conceptId": "C48226", "definition": "The lack of expected or desired effect related to a therapy. (NCI)", "preferredTerm": "Lack of Efficacy", "submissionValue": "TREATMENT FAILURE"}, {"conceptId": "C123645", "definition": "Leaving no doubt; not open to question. (NCI)", "preferredTerm": "Unequivocal", "submissionValue": "UNEQUIVOCAL"}, {"conceptId": "C123617", "definition": "An increase in lesion size, based on a pre-defined threshold, or the development of new lesion(s), marked central fill-in of a lesion, or new enhancement of a previously homogeneously hypoattenuating nonenhancing mass.", "preferredTerm": "Unfavorable Response", "submissionValue": "UNFAVORABLE RESPONSE"}, {"conceptId": "C123618", "definition": "Partial response with additional serum and urine M-protein reduction, but not meeting complete response.", "preferredTerm": "Very Good Partial Response", "submissionValue": "VGPR", "synonyms": ["Very Good Partial Remission", "Very Good Partial Response"]}, {"conceptId": "C71686", "definition": "In a declining condition or state.", "preferredTerm": "Worse", "submissionValue": "WORSENED"}]}